Diese Website verwendet Cookies, damit wir dir die bestmögliche Benutzererfahrung bieten können. Cookie-Informationen werden in deinem Browser gespeichert und führen Funktionen aus, wie das Wiedererkennen von dir, wenn du auf unsere Website zurückkehrst, und hilft unserem Team zu verstehen, welche Abschnitte der Website für dich am interessantesten und nützlichsten sind.
Deal News - GreenGate Partners advises Boehringer Ingelheim Venture Fund (BIVF) on EUR 9.1 Mio. seed-extension financing round of Refoxy Pharma GmbH
The preclinical biotech company Refoxy Pharma, based in Berlin, is the first company to develop small molecule activators of the transcription factor FOXO3 for the promising treatment of age-related diseases.
FOXO3 is a gene that is strongly associated with a longer and healthier human lifespan. It helps organs to combat stress and is therefore a compelling target for pharmaceutical research.
The funding will enable the company to further develop novel therapeutic treatments for various indications, including the chronic, age-related and severe lung disease idiopathic pulmonary fibrosis (IPF).
About Boehringer Ingelheim Venture Fund
The Fund, based in Ingelheim am Rhein, supports over 40 companies and offers partners expertise in pharmaceutical research, science and management. With a fund volume of EUR 350 million, BIVF invests in innovative biotechnology companies focusing on therapeutics to advance biomedical research and improve patient care.
More Deal News
13. Januar 2025
Secondary Private Equity und Private Debt: Tobias Schönhaar im Gespräch mit dem VC-Magazin
21. Dezember 2024
Deal News – GreenGate Partners advised the shareholders of deviceTRUST GmbH on the sale to Cloud Software Group
6. Dezember 2024
Deal News – GreenGate Partners advises Nauta Capital and InReach Ventures on EUR 4 Mio. series seed financing round of NetBird GmbH
Advisors GreenGate Partners
René Spitz LL.M. (USC) (Partner/Corporate) (Lead)
Dr. Sven Schilf (Partner/IP, IT & Life Sciences)
Constantin Forstner (Associate/Corporate)
Dr. Leonie Singer, LLM (Sydney) (Associate/Corporate)
Carl von Sydow (Associate/Corporate)
Lenz Hesse (Associate/IP, IT & Life Sciences)